Announce Date | 11/07/2024 |
EPS Normalized Actual | $0.16 (Beat by $0.01) |
EPS GAAP Actual | $0.16 (Beat by $0.01) |
Revenue Actual | $0.094363B |
Revenue Surprise | Beat by $94.363M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.0229 |
EPS GAAP Estimate | $-0.0229 |
Revenue Estimate | $0.0777B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 1.745 | 10.2 | 1.65 | 1.84 | 2 |
Dec 2025 | 0.415 | 42.89 | 0.33 | 0.5 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2024 (Sep 2024) | 0.17 | -1.37141 | 0.094363B | 37.31% | -23.95M |
FQ2 2024 (Jun 2024) | -0.35 | -0.35 | 0.076478B | 37.26% | 76.48M |
FQ1 2024 (Mar 2024) | 0.0085 | 0.0085 | 0.055848B | 7.89% | 55.85M |
FQ4 2023 (Dec 2023) | 0.47 | 0.47 | 0.099538B | -1.37% | 99.54M |
FQ3 2023 (Sep 2023) | -0.21 | -0.21 | 0.059158B | 13.28% | 59.16M |
FQ2 2023 (Jun 2023) | -0.93 | -0.93 | 0.047982B | 13.93% | 47.98M |
FQ1 2023 (Mar 2023) | -0.4 | -0.4 | 0.051444B | 100% | 51.44M |
FQ4 2009 (Dec 2009) | -0.08 | -0.08 | 9.5802E-5B | 100% | 0.1M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.0229
Consensus Revenue Estimates
0.0777B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.37 | -- | 0.34708 | 0.38723 | 0 |
FQ3 2026 (Jul 2026) | 0.03 | -- | 0.02814153 | 0.03139663 | 0 |
FQ2 2026 (Jun 2026) | 0.03 | -- | 0.02814153 | 0.03139663 | 0 |
FQ1 2026 (Mar 2026) | 0.12 | -- | 0.11257 | 0.12559 | 0 |
FQ4 2025 (Oct 2025) | 0.22118 | -- | 0.20748 | 0.23148 | 1 |
FQ3 2025 (Jul 2025) | -0.0229 | 842.36 | -0.0239661 | -0.02148137 | 1 |
FQ2 2025 (Jun 2025) | -0.0229 | -1428.38 | -0.02441159 | -0.02106824 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.1B | -- | 0.1B | 0.1B | 2 |
FQ3 2026 (Jul 2026) | 0.08B | -- | 0.08B | 0.08B | 2 |
FQ2 2026 (Jun 2026) | 0.08B | -- | 0.08B | 0.08B | 2 |
FQ1 2026 (Mar 2026) | 0.08B | -- | 0.08B | 0.09B | 2 |
FQ4 2025 (Oct 2025) | 0.1B | -- | 0.09B | 0.1B | 1 |
FQ3 2025 (Jul 2025) | 0.08B | -21.45 | 0.07B | 0.08B | 1 |
FQ2 2025 (Jun 2025) | 0.08B | 1.57 | 0.07B | 0.08B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | 1.54141 | 0.17 | -1.37141 | -806.71% |
FQ2 2024 (Jun 2024) | -0.35 | -0.35 | 100% | |
FQ1 2024 (Mar 2024) | 0.0085 | 0.0085 | 100% | |
FQ4 2023 (Dec 2023) | 0.47 | 0.47 | 100% | |
FQ3 2023 (Sep 2023) | -0.21 | -0.21 | 100% | |
FQ2 2023 (Jun 2023) | -0.93 | -0.93 | 100% | |
FQ1 2023 (Mar 2023) | -0.4 | -0.4 | 100% | |
FQ4 2009 (Dec 2009) | -0.08 | -0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | $0.12B | $0.09B | $-23.95M | -25.38% |
FQ2 2024 (Jun 2024) | $0B | $0.08B | $76.48M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.06B | $55.85M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.1B | $99.54M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.06B | $59.16M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.05B | $47.98M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.05B | $51.44M | 100% |
FQ4 2009 (Dec 2009) | $0B | $0B | $0.1M | 100% |